Products
Tools
Education
$2.50
$2.41
$16.05
$2.19
$5.5M
-54.27%
This is a preview of the full version of Prosperse
The FDA has approved a protocol amendment for BioCardia's CardiAMP Heart Failure II Trial, allowing more patients to receive the autologous cell therapy. The amendment incorporates a personalized treatment plan based on a pre-procedural cell population analysis, expected to enhance the clinical expe...
Biocardia, Inc.
Aug 21, 2024
Date: Oct 25, 2024
Date: Oct 24, 2024